An introduction to MS imaging in drug discovery and development

Bioanalysis

Volumn 7, Issue 20, 2015, Pages 2621-2627

  Lodén, Henrik ^a   Shariatgorji, Mohammadreza ^a   Nilsson, Anna ^a   Andrén, Per E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; LIPID; PEPTIDE; PROTEIN; DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD BRAIN BARRIER; DRUG ABSORPTION; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEASUREMENT ACCURACY; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TOXICOLOGY; ANIMAL; BRAIN; HUMAN; KIDNEY; METABOLISM; PATHOLOGY; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG DISCOVERY; HUMANS; KIDNEY; PHARMACEUTICAL PREPARATIONS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84946887497     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.15.186     Document Type: Article

References (37)

1. Nilsson A, Goodwin RJ, Shariatgorji M, Vallianatou T, Webborn PJ, Andren PE. Mass spectrometry imaging in drug development. Anal. Chem. 87(3), 1437-1455 (2015
2. Prideaux B, Stoeckli M. Mass spectrometry imaging for drug distribution studies. J. Proteomics 75(16), 4999-5013 (2012
3. Solon E, Schweitzer A, Stoeckli M, Prideaux B. Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development. AAPS J. 12(1), 11-26 (2010
4. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69(23), 4751-4760 (1997
5. Prestidge CA, Barnes TJ, Skinner W. Time-of-flight secondary-ion mass spectrometry for the surface characterization of solid-state pharmaceuticals. J. Pharm. Pharmacol. 59(2), 251-259 (2007
6. Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306(5695), 471-473 (2004
7. Eikel D, Vavrek M, Smith S, et al. Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example. Rapid Commun. Mass Spectrom. 25(23), 3587-3596 (2011
8. Swales JG, Tucker JW, Strittmatter N, et al. Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis. Anal. Chem. 86(16), 8473-8480 (2014
9. Knochenmuss R. Ion formation mechanisms in UV-MALDI. Analyst 131(9), 966-986 (2006
10. Shariatgorji M, Svenningsson P, Andren PE. Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology 39(1), 34-49 (2014
11. Mclean JA, Ridenour WB, Caprioli RM. Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. J. Mass Spectrom. 42(8), 1099-1105 (2007
12. Matz LM, Hill HH Jr, Beegle LW, Kanik I. Investigation of drift gas selectivity in high resolution ion mobility spectrometry with mass spectrometry detection. J. Am. Soc. Mass Spectrom. 13(4), 300-307 (2002
13. Goodwin RJ, Iverson SL, Andren PE. The significance of ambient-temperature on pharmaceutical and endogenous compound abundance and distribution in tissues sections when analyzed by matrix-assisted laser desorption/ionization mass spectrometry imaging. Rapid Commun. Mass Spectrom. 26(5), 494-498 (2012
14. Goodwin RJ. Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. J. Proteomics 75(16), 4893-4911 (2012
15. Svensson M, Boren M, Skold K, et al. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J. Proteome Res. 8(2), 974-981 (2009
16. Goodwin RJ, Nilsson A, Borg D, et al. Conductive carbon tape used for support and mounting of both whole animal and fragile heat-treated tissue sections for MALDI MS imaging and quantitation. J. Proteomics 75(16), 4912-4920 (2012
17. Jurchen JC, Rubakhin SS, Sweedler JV. MALDI-MS imaging of features smaller than the size of the laser beam. J. Am. Soc. Mass Spectrom. 16(10), 1654-1659 (2005
18. Shariatgorji M, Kallback P, Gustavsson L, et al. ControlledpH tissue cleanup protocol for signal enhancement of small molecule drugs analyzed by MALDI-MS imaging. Anal. Chem. 84(10), 4603-4607 (2012
19. Chacon A, Zagol-Ikapitte I, Amarnath V, et al. On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometry. J. Mass Spectrom. 46(8), 840-846 (2011
20. Shariatgorji M, Nilsson A, Goodwin RJ, et al. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron 84(4), 697-707 (2014
21. Shariatgorji M, Nilsson A, Kallback P, et al. Pyrylium salts as reactive matrices for MALDI-MS imaging of biologically active primary amines. J. Am. Soc. Mass Spectrom. 26(6), 934-939 (2015
22. Kallback P, Shariatgorji M, Nilsson A, Andren PE. Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J. Proteomics 75(16), 4941-4951 (2012
23. Stoeckli M, Staab D, Schweitzer A. Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections. Int. J. Mass Spectrom. 260(2-3), 195-202 (2007
24. Hamm G, Bonnel D, Legouffe R, et al. Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor. J. Proteomics 75(16), 4952-4961 (2012
25. Hochart G, Hamm G, Stauber J. Label-free MS imaging from drug discovery to preclinical development. Bioanalysis 6(20), 2775-2788 (2014
26. Nilsson A, Fehniger TE, Gustavsson L, et al. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS ONE 5(7), e11411 (2010
27. Pirman DA, Reich RF, Kiss A, Heeren RMA, Yost RA. Quantitative MALDI tandem mass spectrometric imaging of cocaine from brain tissue with a deuterated internal standard. Anal. Chem. 85(2), 1081-1089 (2013
28. Pellegatti M, Pagliarusco S. Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review. Expert Opin. Drug Metabol. Toxicol. 7(2), 137-146 (2011
29. Nilsson A, Forngren B, Bjurstrom S, et al. In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studies. PLoS ONE 7(10), e47353 (2012
30. Khatib-Shahidi S, Andersson M, Herman JL, Gillespie TA, Caprioli RM. Direct molecular analysis of wholebody animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 78(18), 6448-6456 (2006
31. Goodwin RJ, Mackay CL, Nilsson A, et al. Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method. Anal. Chem. 83(24), 9694-9701 (2011
32. Rip J, Schenk GJ, De Boer AG. Differential receptormediated drug targeting to the diseased brain. Expert Opin. Drug Deliv. 6(3), 227-237 (2009
33. Liu X, Ide JL, Norton I, et al. Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci. Rep. 3, 2859 (2013
34. Pardridge WM. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metabol. 32(11), 1959-1972 (2012
35. Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv. 3(2), 90-105, 151 (2003
36. Castellino S, Groseclose MR, Sigafoos J, et al. Central nervous system disposition and metabolism of fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity. Chem. Res. Toxicol. 26(2), 241-251 (2013
37. Salphati L, Shahidi-Latham S, Quiason C, et al. Distribution of the phosphatidylinositol 3-kinase inhibitors pictilisib (GDC-0941) and GNE-317 in U87 and GS2 intracranial glioblastoma models-assessment by matrix-assisted laser desorption ionization imaging. Drug Metabol. Dispos. 42(7), 1110-1116 (2014